Alexandra Arvanitaki, Gerhard Diller, George Giannakoulas
PURPOSE OF REVIEW: To analyze the pathophysiologic importance of the right heart in different types of congenital heart disease (CHD), summarize current diagnostic modalities, and discuss treatment options. RECENT FINDINGS: The right ventricle (RV) plays a key role in disease progression and prognosis, either as the subpulmonary or as the systemic ventricle. Volume and/or pressure overload as well as intrinsic myocardial disease are the main factors for RV remodeling...
September 29, 2023: Current Heart Failure Reports
Adamu T Bekele
PURPOSE OF REVIEW: Heart failure is defined as a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood. The natriuretic peptide is known to exert its biological action on the kidney, heart, blood vessels, renin-angiotensin system, autonomous nervous system, and central nervous system. The natriuretic peptide-natriuretic receptor system plays an important role in the regulation of blood pressure and body fluid volume through its pleiotropic effects...
September 15, 2023: Current Heart Failure Reports
Theo E Meyer, Kai Chen, Matthew W Parker, Jeff Shih, Youssef Rahban
PURPOSE OF THE REVIEW: This review focuses on broader perspectives of mitral regurgitation (MR) in patients with heart failure. RECENT FINDINGS: The ratio of regurgitant volume to end-diastolic volume appears to help identify patients who may benefit from valve interventions. Secondary MR is not only attributed to geometric changes of the LV but also related to the structural changes in the mitral valve that include fibrosis of the mitral leaflets and changes in the extracellular matrix...
September 11, 2023: Current Heart Failure Reports
Tiffany Yuen, Pishoy Gouda, Robert Margaryan, Justin Ezekowitz
PURPOSE OF REVIEW: Heart failure (HF) is one of the leading causes of cardiac morbidity and mortality around the world. Our evolving understanding of the cellular and molecular pathways of HF has led to the identification and evaluation of a growing number of HF biomarkers. Natriuretic peptides remain the best studied and understood HF biomarkers, with demonstrated clinical utility in the diagnosis and prognostication of HF. Less commonly understood is the utility of HF biomarkers for guiding and monitoring treatment response...
September 7, 2023: Current Heart Failure Reports
Paolo Severino, Silvia Prosperi, Andrea D'Amato, Claudia Cestiè, Vincenzo Myftari, Viviana Maestrini, Lucia Ilaria Birtolo, Domenico Filomena, Marco Valerio Mariani, Carlo Lavalle, Roberto Badagliacca, Massimo Mancone, Francesco Fedele, Carmine Dario Vizza
The purpose of this review is to explore the benefits and controversies that telemedicine (TM), applied to patients with heart failure (HF), can provide in terms of diagnosis, therapeutic management, and prognosis improvement. During the coronavirus disease 19 (COVID-19) outbreak, TM emerged as the most effective and feasible method available to ensure continuous care for chronic diseases. Among these, HF, characterized by high mortality, morbidity, and the need for frequent visits, may benefit of the TM role...
September 4, 2023: Current Heart Failure Reports
Mariëlle C van de Veerdonk, Gianluigi Savarese, M Louis Handoko, Joline W J Beulens, Folkert Asselbergs, Alicia Uijl
REVIEW PURPOSE: This review summarises key findings on treatment effects within phenotypical clusters of patients with heart failure (HF), making a distinction between patients with preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF). FINDINGS: Treatment response differed among clusters; ACE inhibitors were beneficial in all HFrEF phenotypes, while only some studies show similar beneficial prognostic effects in HFpEF patients. Beta-blockers had favourable effects in all HFrEF patients but not in HFpEF phenotypes and tended to worsen prognosis in older, cardiorenal patients...
September 2, 2023: Current Heart Failure Reports
Silvio Nunes Augusto, Pieter Martens
PURPOSE OF REVIEW: The goal of the current review is to give an overview regarding the pathophysiology of iron deficiency in heart failure and how different laboratory tests change in the setting of heart failure. RECENT FINDINGS: Recent studies have questioned the current employed definition of iron deficiency in the field of heart failure, as patients with ferritin < 100ng/ml but TSAT > 20% have a better prognosis, no iron deficiency on bone marrow staining, and altered treatment response to ferric carboxymaltose...
August 26, 2023: Current Heart Failure Reports
Sumeet Vaikunth, Swethika Sundaravel, Joshua Saef, Juan Ortega-Legaspi
PURPOSE OF REVIEW: This paper reviews the latest literature on the growing field of heart failure in the adult congenital heart disease population. RECENT FINDINGS: After highlighting the increasing prevalence and a few of the unique potential causes, including the concept of early senescence, this review begins with novel medical management strategies such as the angiotensin II receptor blocker and neprilysin inhibitors and sodium glucose cotransporter-2 inhibitors...
August 16, 2023: Current Heart Failure Reports
Emily B Schulman-Geltzer, Helen E Collins, Bradford G Hill, Kyle L Fulghum
PURPOSE OF REVIEW: Pregnancy and exercise are systemic stressors that promote physiological growth of the heart in response to repetitive volume overload and maintenance of cardiac output. This type of remodeling is distinct from pathological hypertrophy and involves different metabolic mechanisms that facilitate growth; however, it remains unclear how metabolic changes in the heart facilitate growth and if these processes are similar in both pregnancy- and exercise-induced cardiac growth...
August 15, 2023: Current Heart Failure Reports
Elizabeth A V Jones
PURPOSE OF REVIEW: Though patient studies have been important for understanding the disease, research done in animals and cell culture complement our knowledge from patient data and provide insight into the mechanism of the disease. Understanding how COVID causes damage to the heart is essential to understanding possible long-term consequences. RECENT FINDINGS: COVID-19 is primarily a disease that attacks the lungs; however, it is known to have important consequences in many other tissues including the heart...
August 1, 2023: Current Heart Failure Reports
S Crespo-Aznarez, A Campos-Sáenz de Santamaría, M Sánchez-Marteles, V Garcés-Horna, C Josa-Laorden, I Giménez-López, J I Pérez-Calvo, J Rubio-Gracia
PURPOSE OF THE REVIEW: An efficient diuretic response is vital during cardiac decompensation in heart failure (HF) patients. The increase in intra-abdominal pressure (IAP) could be one of the keys for understanding cardiorenal syndrome and guiding diuretic treatment during hospitalization. In this review, we analyze the relationship between IAP and diuretic response in HF patients. RECENT FINDINGS: Increased IAP is associated with worsening renal function (WRF) in patients with advanced HF...
July 29, 2023: Current Heart Failure Reports
Pablo Díez-Villanueva, César Jiménez-Méndez, María Thiscal López-Lluva, Samantha Wasniewski, Jorge Solís, Leticia Fernández-Friera, Manuel Martínez-Sellés
PURPOSE OF REVIEW: Heart failure (HF) entails poor prognosis, with high morbidity and mortality burden, particularly in elderly patients. Notably, important sex differences have been described between men and women with HF. In this regard, some biological and sociocultural aspects related to sex may play a key role in the different development and prognosis of HF in elderly men and women. RECENT FINDINGS: Important differences between men and women with HF, especially in the elderly population, have been specifically addressed in recent studies...
July 27, 2023: Current Heart Failure Reports
Annalisa Caputo, Silvia Papa, Giovanna Manzi, Domenico Laviola, Tommaso Recchioni, Paolo Severino, Carlo Lavalle, Viviana Maestrini, Massimo Mancone, Roberto Badagliacca, Carmine Dario Vizza
PURPOSE OF REVIEW: The purpose of this review is to overview the most relevant and recent knowledge regarding medical management in pulmonary arterial hypertension (PAH). RECENT FINDINGS: Evidence has shown that PAH patients' quality of life and prognosis depend on the capability of the RV to adapt to increased afterload and to fully recover in response to substantially reduced pulmonary vascular resistance obtained with medical therapy. Data from recent clinical studies show that more aggressive treatment strategies, especially in higher risk categories, determine larger afterload reductions, consequentially increasing the probability of achieving right heart reverse remodeling, therefore improving the patients' survival and quality of life...
July 24, 2023: Current Heart Failure Reports
Claartje Meijs, M Louis Handoko, Gianluigi Savarese, Robin W M Vernooij, Ilonca Vaartjes, Amitava Banerjee, Stefan Koudstaal, Jasper J Brugts, Folkert W Asselbergs, Alicia Uijl
REVIEW PURPOSE: This systematic review aims to summarise clustering studies in heart failure (HF) and guide future clinical trial design and implementation in routine clinical practice. FINDINGS: 34 studies were identified (n = 19 in HF with preserved ejection fraction (HFpEF)). There was significant heterogeneity invariables and techniques used. However, 149/165 described clusters could be assigned to one of nine phenotypes: 1) young, low comorbidity burden; 2) metabolic; 3) cardio-renal; 4) atrial fibrillation (AF); 5) elderly female AF; 6) hypertensive-comorbidity; 7) ischaemic-male; 8) valvular disease; and 9) devices...
July 21, 2023: Current Heart Failure Reports
Michał Tkaczyszyn, Marat Fudim, Piotr Ponikowski, Jan Biegus
PURPOSE OF REVIEW: Iron deficiency (ID) complicates heart failure (HF) at different stages of the natural history of the disease; however, this frequent comorbidity is still not comprehensively understood and investigated in terms of pathophysiology. Intravenous iron therapy with ferric carboxymaltose (FCM) should be considered to improve the quality of life, exercise capacity, and symptoms in stable HF with ID, as well as to reduce HF hospitalizations in iron-deficient patients stabilized after an episode of acute HF...
July 10, 2023: Current Heart Failure Reports
Isabel Wees, Nicholas S Hendren, Gurbakhash Kaur, Lori R Roth, Justin L Grodin
PURPOSE OF REVIEW: Light chain (AL) amyloidosis can cause an infiltrative cardiomyopathy that can result in symptomatic heart failure. The vague, nonspecific onset of signs and symptoms may lead to a delay in diagnosis and treatment leading to poor outcomes. Cardiac biomarkers, such as troponins and natriuretic peptides, play a pivotal role in diagnosis, determining prognosis, and assessing treatment response in patients with AL amyloidosis. Because of the evolving landscape for both diagnosis and treatment of AL cardiac amyloidosis, we review the critical role these and other biomarkers play in the clinical management of this disease...
July 10, 2023: Current Heart Failure Reports
Michael A Fuery, Bashar Kadhim, Marc D Samsky, James V Freeman, Katherine Clark, Nihar R Desai, Francis P Wilson, Treeny Ahmed, Tariq Ahmad
PURPOSE: A majority of clinical decisions use the electronic health record (EHR) and there is an unmet need to use its capability to help providers to make evidence-based decisions that improve care for heart failure patients. These electronic nudges are rooted in the human psychology of decision-making and often target specific cognitive biases. This review outlines the development of novel EHR nudges and specific lessons learned from each experience to inform the development of future interventions...
August 2023: Current Heart Failure Reports
Sara Vázquez-Calvo, Ivo Roca-Luque, Till F Althoff
PURPOSE OF REVIEW: Despite substantial progress in medical and device-based heart failure (HF) therapy, ventricular arrhythmias (VA) and sudden cardiac death (SCD) remain a major challenge. Here we review contemporary management of VA in the context of HF with one particular focus on recent advances in imaging and catheter ablation. RECENT FINDINGS: Besides limited efficacy of antiarrhythmic drugs (AADs), their potentially life-threatening side effects are increasingly acknowledged...
August 2023: Current Heart Failure Reports
Riccardo M Inciardi, Alessandro Mantovani, Giovanni Targher
PURPOSE OF THE REVIEW: Non-alcoholic fatty liver disease (NAFLD) and heart failure (HF) are two chronic diseases that have become important global public health problems. This narrative review provides a comprehensive overview of the association between NAFLD and increased risk of new-onset HF, briefly discusses the putative biological mechanisms linking these two conditions, and summarizes targeted pharmacotherapies for NAFLD that might also beneficially affect cardiac complications leading to new-onset HF...
July 4, 2023: Current Heart Failure Reports
Daniela Maidana, Clara Bonanad, Carolina Ortiz-Cortés, Andrea Arroyo-Álvarez, Guillermo Barreres-Martín, Carles Muñoz-Alfonso, Eva Maicas-Alcaine, Cristina García-Pérez, Andrea Aparici-Redal, Victòria Freitas-Durks, Alberto Esteban-Fernández
PURPOSE OF REVIEW: The literature on the importance of sex in heart failure diagnosis is scarce. This review aims to summarize current knowledge on sex differences regarding the diagnosis of heart failure. RECENT FINDINGS: Comorbidities are frequent in patients with heart failure, and their prevalence differs between sexes; some differences in symptomatology and diagnostic imaging techniques were also found. Biomarkers also usually show differences between sexes but are not significant enough to establish sex-specific ranges...
June 13, 2023: Current Heart Failure Reports
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.